Related Experiment Video
Updated: Aug 4, 2026
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Prothrombin time. Determination by a whole blood micro-method for control of anticoagulant therapy
Abstract:
A micro technique that is here described for "prothrombin time" determinations, employing capillary whole blood, provides a range of values which is closely correlated with the Quick one-stage plasma method, thus providing inter-changeability of results both in normal persons and in patients who have been treated with anticoagulant drugs. Avoidance of the use of a water bath and centrifuge permit this technique to yield immediate results at the bedside, in the office or in the patient's home. The use of a whole blood instead of a plasma technique lends additional safety to control of anticoagulant medication, since it may reflect depression of clotting factors not apparent by the usual plasma methods.
Insights
A new micro technique using capillary whole blood for prothrombin time testing offers immediate, interchangeable results with plasma methods. This bedside-friendly approach enhances anticoagulant therapy monitoring safety.
Area of Science:
- Hematology
- Clinical Chemistry
- Diagnostic Techniques
Background:
- Accurate prothrombin time (PT) measurement is crucial for monitoring anticoagulant therapy and assessing hemostasis.
- Traditional PT methods often require laboratory equipment, limiting point-of-care applications.
- Existing plasma-based methods may not fully reflect the impact of anticoagulants on all clotting factors.
Purpose of the Study:
- To introduce and validate a novel micro technique for prothrombin time determination.
- To assess the correlation and interchangeability of results with a standard plasma-based method.
- To evaluate the suitability of the technique for point-of-care settings and its safety in anticoagulant monitoring.
Main Methods:
- Development of a micro technique utilizing capillary whole blood for PT measurements.
- Comparison of results obtained from the micro technique with the Quick one-stage plasma method.
- Evaluation of the technique's performance in normal individuals and patients on anticoagulant drugs.
Main Results:
- The micro whole blood technique demonstrated a close correlation with the Quick one-stage plasma method.
- Results were interchangeable between the two methods for both healthy subjects and patients receiving anticoagulants.
- The technique eliminated the need for a water bath and centrifuge, enabling immediate bedside results.
Conclusions:
- The described micro whole blood technique provides a rapid, reliable, and interchangeable alternative for prothrombin time testing.
- Its point-of-care applicability enhances convenience and accessibility for patient monitoring.
- The whole blood approach offers improved safety in anticoagulant therapy management by potentially detecting clotting factor depression missed by plasma methods.
